Related Experiment Video
Updated: May 27, 2026

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
Published on: November 4, 2022
Stem cells as a therapeutic approach to chronic kidney diseases
Sargis Sedrakyan1, Susanne Angelow, Roger E De Filippo
1Division of Urology, Saban Research Institute, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA 90027, USA.
Abstract:
Much attention recently has been focused on stem cell technology as a possible alternative modality of treatment of a variety of diseases. Chronic kidney disease is a serious health problem and most chronic kidney diseases share in common the presence of interstitial and glomerular fibrosis, regardless of the underlying cause. To date there are no specific therapies aimed at treating fibrosis in the kidney. In a novel effort to address the underlying pathology in kidney disease, researchers are demonstrating that stem cell therapy can attenuate fibrosis in chronic kidney disease in animal models. This review will focus on the recent developments in stem cell research and their possible implications to treat chronic kidney disease.
Insights
Stem cell therapy shows promise for treating kidney disease by reducing fibrosis. This review explores recent advancements in stem cell research for chronic kidney disease applications.
Area of Science:
- Regenerative Medicine
- Nephrology
- Biomedical Engineering
Background:
- Chronic kidney disease (CKD) is a significant global health issue.
- Fibrosis, affecting glomeruli and interstitium, is a common pathological feature across various CKD causes.
- Current treatments for kidney fibrosis are limited.
Purpose of the Study:
- To review recent developments in stem cell technology for potential CKD treatment.
- To explore the therapeutic implications of stem cells in attenuating kidney fibrosis.
Main Methods:
- Review of current scientific literature on stem cell therapy and kidney disease.
- Analysis of preclinical studies demonstrating stem cell efficacy in animal models of CKD.
Main Results:
- Stem cell therapy has demonstrated the potential to reduce interstitial and glomerular fibrosis in animal models of CKD.
- Emerging research highlights stem cells as a viable therapeutic strategy for kidney fibrosis.
Conclusions:
- Stem cell therapy represents a promising novel approach to address the underlying pathology of CKD, specifically fibrosis.
- Further research and clinical translation are warranted to establish stem cell therapy as a standard treatment for chronic kidney disease.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Chronic Kidney Disease I: Introduction
Stem Cell Culture
iPS Cell Differentiation
Kidney Transplant I: Introduction

